Pharsight

Drugs that contain Brimonidine Tartrate; Timolol Maleate

1. Combigan patents expiration

COMBIGAN's oppositions filed in EPO
COMBIGAN Litigations
Drug Patent Number Company Drug Patent Title Drug Patent Expiry Activity Alert
These drug patents protects the active chemical substance. Only drug patent owner can launch products that use this active substance.
US7642258 ABBVIE INC Combination of brimonidine and timolol for topical ophthalmic use
Apr, 2022

(1 year, 11 months ago)

These drug patents focus on the other aspects of the active substance like dosage, mode of administration (oral, tablet, capsules, liquids etc).
US7320976 ABBVIE INC Combination of brimonidine and timolol for topical ophthalmic use
Apr, 2022

(1 year, 11 months ago)

US8133890 ABBVIE INC Combination of brimonidine and timolol for topical ophthalmic use
Apr, 2022

(1 year, 11 months ago)

US9770453 ABBVIE INC Combination of brimonidine and timolol for topical ophthalmic use
Apr, 2022

(1 year, 11 months ago)

US9907801 ABBVIE INC Combination of brimonidine and timolol for topical ophthalmic use
Apr, 2022

(1 year, 11 months ago)

US8354409 ABBVIE INC Combination of brimonidine and timolol for topical ophthalmic use
Apr, 2022

(1 year, 11 months ago)

US8748425 ABBVIE INC Combination of brimonidine and timolol for topical ophthalmic use
Apr, 2022

(1 year, 11 months ago)

US9907802 ABBVIE INC Combination of brimonidine and timolol for topical ophthalmic use
Apr, 2022

(1 year, 11 months ago)

US9474751 ABBVIE INC Combination of brimonidine and timolol for topical ophthalmic use
Apr, 2022

(1 year, 11 months ago)

US7030149 ABBVIE INC Combination of brimonidine timolol for topical ophthalmic use
Apr, 2022

(1 year, 11 months ago)

US7323463 ABBVIE INC Combination of brimonidine and timolol for topical ophthalmic use
Jan, 2023

(1 year, 2 months ago)

Market Authorisation Date: 30 October, 2007

Treatment: Reduction of elevated intraocular pressure (iop) in patients with glaucoma or ocular hypertension who require adjunctive or replacement therapy due to inadequately controlled iop. dose is one drop of ...

Dosage: SOLUTION/DROPS;OPHTHALMIC

How can I launch a generic of COMBIGAN before it's drug patent expiration?
More Information on Dosage

COMBIGAN family patents

Family Patents